BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 940 filers reported holding BAXTER INTL INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $344,400,000 | -63.4% | 4,000,000 | -65.5% | 4.72% | -68.6% |
| Q1 2020 | $940,180,000 | -35.8% | 11,580,000 | -33.8% | 15.00% | -10.8% |
| Q4 2019 | $1,463,350,000 | -0.7% | 17,500,000 | +3.9% | 16.83% | -3.9% |
| Q3 2019 | $1,473,870,000 | -21.8% | 16,850,000 | -26.7% | 17.51% | -20.6% |
| Q2 2019 | $1,883,700,000 | -17.3% | 23,000,000 | -17.9% | 22.06% | -12.9% |
| Q1 2019 | $2,276,680,000 | +23.5% | 28,000,000 | 0.0% | 25.31% | -10.6% |
| Q4 2018 | $1,842,960,000 | -33.6% | 28,000,000 | -22.2% | 28.32% | +46.0% |
| Q3 2018 | $2,775,240,000 | +4.4% | 36,000,000 | 0.0% | 19.40% | +4.7% |
| Q2 2018 | $2,658,240,000 | +13.5% | 36,000,000 | 0.0% | 18.52% | +5.4% |
| Q1 2018 | $2,341,440,000 | +0.6% | 36,000,000 | 0.0% | 17.58% | +4.7% |
| Q4 2017 | $2,327,040,000 | -9.6% | 36,000,000 | -12.2% | 16.80% | -22.3% |
| Q3 2017 | $2,572,750,000 | +3.7% | 41,000,000 | 0.0% | 21.63% | -1.7% |
| Q2 2017 | $2,482,140,000 | +4.0% | 41,000,000 | -10.9% | 22.00% | -5.5% |
| Q1 2017 | $2,385,560,000 | +3.7% | 46,000,000 | -11.4% | 23.28% | +3.1% |
| Q4 2016 | $2,301,324,000 | -6.8% | 51,901,767 | 0.0% | 22.59% | +5.2% |
| Q3 2016 | $2,470,524,000 | +5.3% | 51,901,767 | 0.0% | 21.48% | -4.0% |
| Q2 2016 | $2,346,998,000 | +6.1% | 51,901,767 | -3.6% | 22.37% | +9.8% |
| Q1 2016 | $2,212,158,000 | +7.7% | 53,850,000 | 0.0% | 20.38% | -2.2% |
| Q4 2015 | $2,054,378,000 | +16.1% | 53,850,000 | 0.0% | 20.84% | +24.9% |
| Q3 2015 | $1,768,972,000 | +540.4% | 53,850,000 | +1263.3% | 16.69% | +545.1% |
| Q2 2015 | $276,224,000 | – | 3,950,000 | – | 2.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soditic Asset Management LLP | 186,920 | $7,581,475 | 8.39% |
| Pavadi Capital LLC | 157,727 | $6,397,407 | 6.98% |
| BOONE CAPITAL MANAGEMENT LLC | 354,443 | $14,376,208 | 6.73% |
| Camber Capital Management LP | 3,000,000 | $121,680 | 3.74% |
| Numerai GP LLC | 231,275 | $9,380,514 | 3.14% |
| Sivik Global Healthcare LLC | 150,000 | $6,084 | 2.62% |
| STONERIDGE INVESTMENT PARTNERS LLC | 119,770 | $4,858 | 2.58% |
| PVG ASSET MANAGEMENT CORP | 19,457 | $789,175 | 2.53% |
| Locust Wood Capital Advisers | 1,062,359 | $43,089,281 | 2.52% |
| Dash Acquisitions Inc. | 99,344 | $4,029,376 | 1.87% |